High detection rates of pancreatic cancer across stages by plasma assay of novel methylated DNA markers and CA 19-9

BACKGROUND & AIMS: We have previously identified tissue methylated DNA markers (MDMs) associated with pancreatic ductal adenocarcinoma (PDAC). In this case-control study, we aimed to assess the diagnostic performance of plasma MDMs for PDAC. METHODS: Thirteen MDMs (GRIN2D, CD1D, ZNF781, FER1L4,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Majumder, Shounak, Taylor, William R., Foote, Patrick H., Berger, Calise K., Wu, Chung Wah, Mahoney, Douglas W., Bamlet, William R., Burger, Kelli N., Postier, Neil, de la Fuente, Jaime, Doering, Karen A., Lidgard, Graham P., Allawi, Hatim T., Petersen, Gloria M., Chari, Suresh T., Ahlquist, David A., Kisiel, John B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8102343/
https://ncbi.nlm.nih.gov/pubmed/33593879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-0235
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados